The Death of Revlon for PBCs: Delaware Chancery Blesses the Ultimate Anti-Takeover Shield

The Sacred Cow of Delaware M&A Just Got Slaughtered

For nearly forty years, the fundamental commandment of Delaware corporate law during a change of control has been absolute: when a company is up for sale, the board of directors must abandon all other objectives and focus solely on securing the highest possible price for shareholders. The Revlon doctrine—born from Revlon, Inc. v. MacAndrews & Forbes Holdings, Inc., 506 A.2d 173 (Del. 1986)—has terrorized boards, enriched plaintiff firms, and dictated the outcome of countless billion-dollar bidding wars.

But the Delaware Court of Chancery has just carved out a massive, heavily fortified loophole. In a landmark 2026 ruling, Vice Chancellor Nathan Cook issued the first decision squarely addressing directors’ duties for Public Benefit Corporations (PBCs) in a sale context. The holding is as blunt as it is revolutionary: PBC boards are not required to maximize sale value in a change-of-control transaction.

For corporate practitioners, this is not just a quirky ESG development. It is a fundamental rewriting of M&A defensive strategy. The Chancery Court has officially transformed the PBC from a feel-good marketing gimmick into one of the most formidable anti-takeover shields in American corporate law.

The Legal Landscape: Balancing Purpose and Profit

To understand the gravity of Judge Cook’s ruling, you have to look at the statutory tension that created it. Under Subchapter XV of the Delaware General Corporation Law (DGCL), specifically Del. Code Ann. tit. 8, § 365, directors of a PBC are required to balance three things: the pecuniary interests of the stockholders, the best interests of those materially affected by the corporation's conduct, and the specific public benefit identified in its certificate of incorporation.

Until now, the great unanswered question in Delaware was whether this tripartite balancing act survived a Revlon moment. If a traditional corporation puts itself up for sale, standard fiduciary duties (the "corporate preservation" mandate) evaporate, replaced by the duty to act as auctioneers. Plaintiff attorneys have long argued that once a PBC enters a change-of-control scenario, the financial interests of the shareholders must legally trump the "public benefit."

Judge Cook decisively rejected that premise. The Chancery Court ruled that the statutory mandate of a PBC fundamentally alters the DNA of the directors' fiduciary duties, even at the terminal stage of the company's independent existence.

"The defining feature of a Public Benefit Corporation is its permanent commitment to its stated purpose. To force a PBC board to abandon that purpose at the precise moment of its greatest vulnerability—a change of control—would render the PBC statute illusory."

Why This Matters for Practicing Lawyers

This ruling is a tectonic shift for corporate attorneys advising founders, private equity sponsors, and activist investors. Here is how your practice needs to adapt immediately:

1. The Incorporation Playbook Must Change

If you are representing founders at formation, the PBC election just became your most potent tool for preserving founder vision. Historically, founders relied on dual-class stock structures to maintain control and fend off activists who might demand a lucrative, but mission-destroying, buyout. But dual-class structures face severe pushback from institutional investors and proxy advisors. The PBC structure now offers a judicially validated alternative. If a hostile bidder offers a 40% premium, a traditional board is under immense pressure to sell. A PBC board can now legally reject that premium if the buyer's track record suggests they will gut the company's social or environmental mission.

2. M&A Diligence and Deal Structuring

For M&A practitioners representing buyers, this ruling complicates acquisitions of PBC targets. You can no longer just throw money at the board to win a contested bid. If your client is outbidding a rival, but the rival has made contractual commitments to uphold the target's public benefit, the target board is now legally insulated if they choose the lower bid. Buyers will need to draft binding covenants—such as maintaining employee wages, preserving environmental standards, or continuing specific community investments—to make their bids palatable to a PBC board's balancing mandate.

3. The End of the Standard Merger Strike Suit for PBCs

Litigators, take note: the standard-issue shareholder strike suit just lost its teeth in PBC deals. Under traditional Corwin and Revlon jurisprudence, plaintiffs routinely survived motions to dismiss by alleging the board ran a flawed process that left money on the table. Following Judge Cook's ruling, plaintiffs challenging a PBC sale must now prove that the board's balancing of the financial payout and the public benefit was not just flawed, but entirely irrational or made in bad faith. This elevates the pleading standard to a near-impossible threshold, severely chilling plaintiff-side M&A litigation in this space.

The Takeaway: Delaware Chooses Contract Over Common Law

At its core, this decision aligns perfectly with the Delaware Supreme Court’s broader 2026 counter-revolution favoring private ordering and contractarian principles. By upholding the literal text of the PBC statute over the common law legacy of Revlon, the Chancery Court is sending a clear message to investors: if you buy shares in a Public Benefit Corporation, you are explicitly opting out of the maximization mandate.

For decades, Revlon was the undisputed king of Delaware M&A. With this ruling, the Chancery Court hasn't killed the king, but it has officially banished him from the realm of the Public Benefit Corporation. Corporate counsel must recognize this new reality immediately, or risk committing malpractice at the negotiating table.